| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10484634 | Value in Health | 2014 | 9 Pages |
Abstract
Our findings suggest increased risk of major adverse events associated with SUs as a second-line agent. Quasi-experimental IV methods may be an important alternative to lengthening clinical trials to assess long-term outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Julia C. PhD, Paul R. MD, Walid F. MD, MPH, David MD, Todd A. PharmD, PhD, Steven D. PhD,